|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Accounts receivable(1), net of allowances of $4,378 and $2,755 at September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Inventory | ||||||||||
| Related party asset | ||||||||||
| Warrant asset | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Marketable equity securities | ||||||||||
| Deferred offering costs | ||||||||||
| Total current assets | ||||||||||
| Property and equipment, net | ||||||||||
| Goodwill | ||||||||||
| Warrant asset, less current portion | ||||||||||
| Intangible assets, net | ||||||||||
| Capitalized software, net | ||||||||||
| Marketable equity securities, less current portion | ||||||||||
| Investments and other assets | ||||||||||
| Investment in joint venture | ||||||||||
| Investment in related party | ||||||||||
| Warrant contract asset, less current portion | ||||||||||
| Related party asset, less current portion | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Restricted cash | ||||||||||
| Total Assets | ||||||||||
| Liabilities, Convertible redeemable preferred stock, and Stockholders' equity (deficit) | ||||||||||
| Current Liabilities | ||||||||||
| Accounts payable | ||||||||||
| Related party payable | ||||||||||
| Accrued expenses | ||||||||||
| Deferred revenue | ||||||||||
| Deferred other income | ||||||||||
| Other current liabilities | ||||||||||
| Operating lease liabilities | ||||||||||
| Accrued data licensing fees | ||||||||||
| Accrued dividends | ||||||||||
| Total current liabilities | ||||||||||
| Operating lease liabilities, less current portion | ||||||||||
| Convertible promissory note | ||||||||||
| Warrant liability | ||||||||||
| Other long-term liabilities | ||||||||||
| Revolving credit facility | ||||||||||
| Interest payable | ||||||||||
| Long-term debt, net | ||||||||||
| Convertible senior notes, net | ||||||||||
| Deferred other income, less current portion | ||||||||||
| Deferred revenue, less current portion | ||||||||||
| Total Liabilities | ||||||||||
| Convertible redeemable preferred stock, $0.0001 par value, 20,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively, no shares outstanding at September 30, 2026 and December 31, 2025 | ||||||||||
| Stockholders' equity | ||||||||||
| Common stock value issued | ||||||||||
| Common Class A | ||||||||||
| Common Class B | ||||||||||
| Non-voting Common Stock | ||||||||||
| Treasury Stock, 203,431 and 183,229 shares at September 30, 2026 and December 31, 2025, respectively, at cost | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive income | ||||||||||
| Accumulated deficit | ||||||||||
| Total Stockholders' equity | ||||||||||
| Total Liabilities, Convertible redeemable preferred stock, and Stockholders' equity |
Loading...